Queen's University at Kingston

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1841-10-16

Employees: 1K

Market Cap: -

Website: http://www.queensu.ca

Clinical Trials

Ketogenic Diet Therapy Major Depressive Disorder

Not Applicable

Recruiting

Conditions: Major Depressive Disorder

Interventions: Other: ketogenic diet

First Posted Date: 2022-09-29

Last Posted Date: 2023-11-18

Lead Sponsor: Queen's University

Target Recruit Count: 10

Registration Number: NCT05558995

Locations: 🇨🇦
Queen's University - Kingston General Hospital, Kingston, Ontario, Canada

Effectiveness of the Dynavision Device to Improve Spatial Awareness After Brain Injury

Not Applicable

Recruiting

Conditions: Acute Brain Injury
Stroke

Interventions: Device: Dynavision D2

First Posted Date: 2022-08-18

Last Posted Date: 2023-11-22

Lead Sponsor: Queen's University

Target Recruit Count: 40

Registration Number: NCT05506241

Locations: 🇨🇦
Providence Care Hospital, Kingston, Ontario, Canada

Response Variability to Exercise

Not Applicable

Recruiting

Conditions: Exercise
Cardiorespiratory Fitness

Interventions: Behavioral: Low amount, high intensity exercise
Behavioral: Low amount, low intensity exercise
Behavioral: High amount, high intensity exercise

First Posted Date: 2022-08-11

Last Posted Date: 2023-11-21

Lead Sponsor: Queen's University

Target Recruit Count: 200

Registration Number: NCT05496751

Locations: 🇨🇦
School of Kinesiology and Health Studies, Queen's University, Kingston, Ontario, Canada

Smartphone App-Based Mindfulness Intervention for French and English Speaker Cancer Survivors

Not Applicable

Not yet recruiting

Conditions: Cancer
Psychological

Interventions: Behavioral: Mindfulness

First Posted Date: 2022-07-22

Last Posted Date: 2024-10-18

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 345

Registration Number: NCT05470010

Locations: 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦
BCCA - Victoria, Victoria, British Columbia, Canada
🇨🇦
BCCA - Kelowna, Kelowna, British Columbia, Canada

and more 2 locations

SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer

Phase 3

Recruiting

Conditions: Oropharyngeal Cancer

Interventions: Radiation: Ipsilateral and Contralateral Neck
Other: Lymphatic Mapping with SPECT-CT

First Posted Date: 2022-07-11

Last Posted Date: 2024-12-11

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 510

Registration Number: NCT05451004

Locations: 🇺🇸
Baptist MD Anderson Cancer Center, Jacksonville, Florida, United States
🇺🇸
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
🇺🇸
Moffitt Cancer Center-International Plaza, Tampa, Florida, United States

and more 21 locations

Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:

Recruiting

Conditions: Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma

First Posted Date: 2022-05-12

Last Posted Date: 2024-06-12

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 247

Registration Number: NCT05371808

Locations: 🇨🇦
CancerCare Manitoba, Winnipeg, Manitoba, Canada
🇨🇦
QEII Health Sciences Centre, Halifax, Nova Scotia, Canada
🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

and more 4 locations

The Effect of a Diabetes Self-management Coaching Program for Type 2 Diabetes Patients in the Ethiopian PC.

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2
Type 2 Diabetes

Interventions: Behavioral: Diabetes self-management Coaching
Other: Usual care

First Posted Date: 2022-04-20

Last Posted Date: 2023-12-26

Lead Sponsor: Queen's University

Target Recruit Count: 40

Registration Number: NCT05336019

Locations: 🇨🇦
Fikadu Ambaw Yehualashet, Kingston, Ontario, Canada

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

Phase 2

Recruiting

Conditions: Hodgkin Lymphoma

Interventions: Drug: Gemcitabine
Drug: Brentuximab vedotin
Drug: Dexamethasone
Drug: Pembrolizumab
Drug: Cisplatin

First Posted Date: 2022-01-06

Last Posted Date: 2024-11-08

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 84

Registration Number: NCT05180097

Locations: 🇦🇺
Austin Hospital, Heidelberg, Victoria, Australia
🇨🇦
Verspeeten Family Cancer Centre, London, Ontario, Canada
🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada

and more 10 locations

SuperPath Versus Posterior Approach for THA

Phase 4

Completed

Conditions: Hip Arthropathy
Surgical Approach

Interventions: Procedure: Superpath Approach

First Posted Date: 2021-12-07

Last Posted Date: 2022-04-20

Lead Sponsor: Queen's University

Target Recruit Count: 45

Registration Number: NCT05147207

Locations: 🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada

Remembering Risk Using Visual Risk Display of MINS to Obtain Informed Consent to Undergo Elective Surgery

Not Applicable

Conditions: Risk

Interventions: Other: Visual Aid
Other: Scripted Risk Discussion

First Posted Date: 2021-10-28

Last Posted Date: 2021-10-28

Lead Sponsor: Queen's University

Target Recruit Count: 108

Registration Number: NCT05098535

Locations: 🇨🇦
Kingston Health Sciences Centre, Kingston, Ontario, Canada

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy